Each NeuroPI module is prepared by distinguished faculty who are acknowledge leaders in their respective fields. Each module is composed of a set of multiple-choice items with preferred responses, instructions on how to collect cases to assess one’s practice, and resources for creating and implementing an effective improvement plan. Participants are able to compare their performance pre- and post-intervention to assess what changes have occurred in their practice.
Members: FREE $199.00*
*Free access is limited to one course at a time for eligible members.
- Perform a comprehensive sleep evaluation.*
- Establish correct diagnosis of obstructive sleep apnea using objective tools.
- Assess for comorbidities in obstructive sleep apnea patients.
- Education of patients with obstructive sleep apnea.
- Follow-up visit within eight weeks of CPAP initiation.
- Assess for CPAP compliance using a time measurement system.
- Assess for causes of CPAP noncompliance in appropriate obstructive sleep apnea patients.
- Evaluate for Excessive Daytime Sleepiness.
*The measures featured in this module apply to patients 18 and older.The quality measures listed are for use in NeuroPI only. The measurements in this set do not qualify for the PQRS incentive program and should not be used for accountability or public reporting programs.
As a result of this program, the participant will determine individual practice gaps and address them through a performance improvement plan designed to improve competence, performance, and patient outcomes.
- Interpersonal Skills and Communication
- Medical Knowledge
- Patient Care
- Practice-based Learning and Improvement
Date of Release
August 6, 2015
This module is eligible for CME credits for three years from the release date.
NeuroPI Data Terms & Conditions
The American Academy of Neurology Institute (AANI) no longer requires You (NeuroPI and aan.com user) to provide full date of service (day/month/year); only year of service will be transmitted to and stored by AANI. All previously collected "day" and "month" from date of service records have been deleted from the AANI's NeuroPI database. Accordingly, for NeuroPI, AANI is not requesting or storing any "protected health information" or "limited data sets" as defined by the regulations issued under the Health Insurance Portability and Accountability Act of 1996. The patient data You submit to the AANI through NeuroPI is de-identified health information. You must track patients separately from NeuroPI. Within the NeuroPI modules, Your patients will be identified using a 4-digit patient code that You create. Any other identifying information is strictly prohibited. Please use the NeuroPI Patient Tracker to create Your 4-digit patient codes for Your personal reference. The NeuroPI Patient Tracker must not be shared with AANI.
The American Academy of Neurology Institute either owns or has permission to use all of the NeuroPI module content. You may use these modules for your personal, noncommercial use, but please send permissions requests for any other uses to NeuroPI@aan.com. All of the individual de-identified health information you submit to the AANI through NeuroPI is confidential. Your maintenance of certification ("MOC") credit information is transmitted to the American Board of Psychiatry and Neurology (ABPN) once You've completed a module. You can opt-out of this service in NeuroTracker. Please note, AANI is not a certifying board and members are encouraged to contact ABPN for the most up-to-date information on MOC requirements. You acknowledge that AANI is and shall be deemed the owner of all rights to the aggregate, de-identified data submitted to NeuroPI and subsets of the aggregate data, any and all reports based on the aggregate, de-identified data, and all trademarks and trade secrets arising from or reflected in NeuroPI (collectively, "Aggregate Data"), with the exception of your individual data. AANI has full and unencumbered rights to publish, disclose, distribute, market, sell, and create derivatives of, Aggregate Data in any form.
MARCEL HUNGS, MD, PhD
Assistant Adjunct Clinical Professor of Neurology, Department of Neurology, University of Minnesota, Minneapolis, MN
*Dr. Hungs has received personal compensation from EMD Serono, Pfizer and Teva for participation in the speaker bureau.
DOUGLAS KIRSCH, MD, FAAN, FAASM
Medical Director, Carolinas HealthCare System Sleep Medicine, Carolinas HealthCare System, Charlotte, NC
Clinical Associate Professor, Department of Medicine, UNC School of Medicine
*Dr. Kirsch has nothing to disclose.
RAMAN MALHOTRA, MD
Director, Neurology Residency Program, Co-Director, SLUCare Sleep Disorders Center, Director, Sleep Medicine Fellowship, Assistant Professor of Neurology, Saint Louis University School of Medicine
*Dr. Malhotra has nothing to disclose.
DONALD J. IVERSON, MD, FAAN
Humboldt Neurological Medical Group, Eureka, California
*Dr. Iverson has nothing to disclose.
Program Manager, Online Learning
*Ms. Chamberlain has nothing to disclose.